Breast Cancer Liquid Biopsy Market Share

Statistics for the 2023 & 2024 Breast Cancer Liquid Biopsy market share, created by Mordor Intelligence™ Industry Reports. Breast Cancer Liquid Biopsy share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Breast Cancer Liquid Biopsy Industry

The breast cancer liquid biopsy market is slightly fragmented and competitive and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some of the companies currently dominating the market are Qiagen, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc., Janssen Diagnostics, Biocept Inc., Guardant Health Inc., Myriad Genetics, Adaptive Biotechnologies, Epic Sciences, Fluxion Biosciences Inc., Biodesix, and Illumina Inc.

Breast Cancer Liquid Biopsy Market Leaders

  1. F. Hoffmann-La Roche Ltd

  2. Bio-Rad Laboratories

  3. Johnson & Johnson (Janssen Diagnostics)

  4. Biocept Inc

  5. Qiagen

*Disclaimer: Major Players sorted in no particular order

Breast Cancer Liquid Biopsy Market Concentration

Breast Cancer Liquid Biopsy Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)